Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Chondrodisplasia Punctata of Hip Joints on Routine Radiography Provided a Diagnostic Clue of Zellweger Syndrome.

Kitaoka H, Shitara Y, Kondo U, Kushima R, Omori I.

Pediatr Neurol. 2019 Sep;98:94-95. doi: 10.1016/j.pediatrneurol.2019.03.019. Epub 2019 Mar 29. No abstract available.

PMID:
31023602
2.

Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.

Kaira K, Kawashima O, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Sugano M, Yamamoto R, Osaki T, Tanaka S, Fujita A, Imai H, Kogure Y, Seki Y, Shimizu K, Mogi A, Shitara Y, Oyama T, Kanai Y, Asao T.

Hum Pathol. 2019 Feb;84:142-149. doi: 10.1016/j.humpath.2018.09.020. Epub 2018 Oct 6.

PMID:
30300664
3.

A case report of intracholecystic papillary neoplasm of the gallbladder resembling a submucosal tumor.

Muranushi R, Saito H, Matsumoto A, Kato T, Tanaka N, Nakazato K, Morinaga N, Shitara Y, Ishizaki M, Yoshida T, Aishima S, Shirabe K.

Surg Case Rep. 2018 Sep 27;4(1):124. doi: 10.1186/s40792-018-0524-2.

4.

Concerns About the Study "Congenital Heart Surgery on In-Hospital Mortality in Trisomy 13 and 18".

Shitara Y, Naruse Y, Matsushita R.

Pediatrics. 2018 May;141(5). pii: e20180400A. doi: 10.1542/peds.2018-0400A. No abstract available.

5.

Evidence for β-adrenergic modulation of sweating during incremental exercise in habitually trained males.

Amano T, Shitara Y, Fujii N, Inoue Y, Kondo N.

J Appl Physiol (1985). 2017 Jul 1;123(1):182-189. doi: 10.1152/japplphysiol.00220.2017. Epub 2017 May 4.

6.

Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions.

Shitara Y, Sugiyama Y.

Pharmacol Ther. 2017 Sep;177:67-80. doi: 10.1016/j.pharmthera.2017.02.042. Epub 2017 Feb 27. Review.

PMID:
28249706
7.

[Low-Dose and Interval Administration of Imatinib in a Patient with Liver Metastasis of the Gastrointestinal Stromal Tumor of the Stomach - A Case Report].

Morinaga N, Saito H, Komine C, Matsumoto A, Katoh T, Tanaka N, Nakazato K, Nakamura T, Shitara Y, Ishizaki M.

Gan To Kagaku Ryoho. 2017 Feb;44(2):161-164. Japanese.

PMID:
28223675
8.

Cytokine Profiles in Pericardial Effusion in a Down Syndrome Infant with Transient Abnormal Myelopoiesis.

Shitara Y, Takahashi N, Aoki Y, Kato M, Nishimura R, Tsuchida S, Oka A.

Tohoku J Exp Med. 2017 Feb;241(2):149-153. doi: 10.1620/tjem.241.149.

9.

Hemoglobin phase of oxygenation and deoxygenation in early brain development measured using fNIRS.

Watanabe H, Shitara Y, Aoki Y, Inoue T, Tsuchida S, Takahashi N, Taga G.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1737-E1744. doi: 10.1073/pnas.1616866114. Epub 2017 Feb 14.

10.

Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction.

Hasegawa T, Nakanishi S, Minami K, Higashino H, Kataoka M, Shitara Y, Yamashita S.

Drug Metab Pharmacokinet. 2017 Feb;32(1):69-76. doi: 10.1016/j.dmpk.2016.11.004. Epub 2016 Nov 23.

PMID:
28109684
11.

Molecular genetic analysis of 30 families with Joubert syndrome.

Suzuki T, Miyake N, Tsurusaki Y, Okamoto N, Alkindy A, Inaba A, Sato M, Ito S, Muramatsu K, Kimura S, Ieda D, Saitoh S, Hiyane M, Suzumura H, Yagyu K, Shiraishi H, Nakajima M, Fueki N, Habata Y, Ueda Y, Komatsu Y, Yan K, Shimoda K, Shitara Y, Mizuno S, Ichinomiya K, Sameshima K, Tsuyusaki Y, Kurosawa K, Sakai Y, Haginoya K, Kobayashi Y, Yoshizawa C, Hisano M, Nakashima M, Saitsu H, Takeda S, Matsumoto N.

Clin Genet. 2016 Dec;90(6):526-535. doi: 10.1111/cge.12836. Epub 2016 Sep 26.

PMID:
27434533
12.

Ten-Year Survival of a Patient Treated with Stereotactic Gamma Knife Radiosurgery for Brain Metastases from Colon Cancer with Ovarian and Lymph Node Metastases: A Case Report.

Morinaga N, Tanaka N, Shitara Y, Ishizaki M, Yoshida T, Kouga H, Wakabayashi K, Fukuchi M, Tsunoda Y, Kuwano H.

Case Rep Gastroenterol. 2016 May 19;10(1):199-206. doi: 10.1159/000445976. eCollection 2016 Jan-Apr.

13.

Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Oga EF, Sekine S, Shitara Y, Horie T.

Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):93-108. doi: 10.1007/s13318-015-0296-z. Review.

PMID:
26311243
14.

Population pharmacokinetics of cefditoren pivoxil in non-infected adults.

Matsumoto K, Sato N, Mitomi N, Shitara Y, Shibasaki S.

Jpn J Antibiot. 2014 Feb;67(1):49-66.

PMID:
24809208
15.

Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.

Yajima T, Onozato R, Shitara Y, Mogi A, Tanaka S, Kuwano H.

BMC Res Notes. 2013 Dec 27;6:558. doi: 10.1186/1756-0500-6-558.

16.

A long-term survival case of rectal cancer with multiple pulmonary metastases treated with multidisciplinary chemotherapy.

Ando H, Shitara Y, Mogami Y, Kobayashi T, Yajima T, Tani M, Morinaga N, Ishizaki M, Hashimoto S, Nakabayashi T, Kuwano H.

Int Surg. 2013 Oct-Dec;98(4):311-4. doi: 10.9738/INTSURG-D-12-00036.1. No abstract available.

17.

The role of cyclophilin D in interspecies differences in susceptibility to hepatotoxic drug-induced mitochondrial injury.

Sekine S, Kimura T, Motoyama M, Shitara Y, Wakazono H, Oida H, Horie T.

Biochem Pharmacol. 2013 Nov 15;86(10):1507-14. doi: 10.1016/j.bcp.2013.08.027. Epub 2013 Sep 3.

PMID:
24012842
18.

Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis.

Hamada K, Kakigawa N, Sekine S, Shitara Y, Horie T.

Cancer Chemother Pharmacol. 2013 Oct;72(4):757-65. doi: 10.1007/s00280-013-2238-2. Epub 2013 Aug 21.

PMID:
23963446
19.

Functional connectivity of the cortex of term and preterm infants and infants with Down's syndrome.

Imai M, Watanabe H, Yasui K, Kimura Y, Shitara Y, Tsuchida S, Takahashi N, Taga G.

Neuroimage. 2014 Jan 15;85 Pt 1:272-8. doi: 10.1016/j.neuroimage.2013.04.080. Epub 2013 Apr 28.

PMID:
23631984
20.

The mechanism of the down-regulation of hepatic transporters in rats with indomethacin-induced intestinal injury.

Fujiyama N, Shitara Y, Horie T.

Dig Dis Sci. 2013 Jul;58(7):1891-8. doi: 10.1007/s10620-013-2587-z. Epub 2013 Feb 27.

PMID:
23443493
21.

Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake.

Shitara Y, Takeuchi K, Horie T.

J Pharm Sci. 2013 Sep;102(9):3427-35. doi: 10.1002/jps.23477. Epub 2013 Feb 25.

PMID:
23440887
22.

CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.

Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE.

Transplantation. 2013 Mar 27;95(6):821-7. doi: 10.1097/TP.0b013e31827e6ad9.

23.

Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.

Shitara Y, Nakamichi N, Norioka M, Shima H, Kato Y, Horie T.

Toxicol Sci. 2013 Mar;132(1):32-42. doi: 10.1093/toxsci/kfs330. Epub 2012 Dec 5.

PMID:
23221006
24.

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.

Shitara Y, Maeda K, Ikejiri K, Yoshida K, Horie T, Sugiyama Y.

Biopharm Drug Dispos. 2013 Jan;34(1):45-78. doi: 10.1002/bdd.1823. Review.

PMID:
23115084
25.

Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition.

Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE.

Clin Pharmacol Ther. 2012 Dec;92(6):737-45. doi: 10.1038/clpt.2012.175. Epub 2012 Oct 17.

26.

P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport.

Oga EF, Sekine S, Shitara Y, Horie T.

J Ethnopharmacol. 2012 Dec 18;144(3):612-7. doi: 10.1016/j.jep.2012.10.001. Epub 2012 Oct 11.

PMID:
23064285
27.

Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells.

Oga EF, Sekine S, Shitara Y, Horie T.

Am J Trop Med Hyg. 2012 Jul;87(1):64-9. doi: 10.4269/ajtmh.2012.11-0817.

28.

Successful surgical treatment of a spontaneous rupture of the esophagus diagnosed two days after onset.

Ando H, Shitara Y, Hagiwara K, Hara K, Mogami Y, Kobayashi T, Yajima T, Tani M, Morinaga N, Ishizaki M, Kuwano H.

Case Rep Gastroenterol. 2012 May;6(2):260-5. doi: 10.1159/000338653. Epub 2012 May 8.

29.

Long-lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin A in rats.

Suzuki K, Shitara Y, Fukuda K, Horie T.

J Pharm Sci. 2012 Jul;101(7):2606-15. doi: 10.1002/jps.23174. Epub 2012 Apr 26.

PMID:
22538465
30.

Depression of mitochondrial metabolism by downregulation of cytoplasmic deacetylase, HDAC6.

Kamemura K, Ogawa M, Ohkubo S, Ohtsuka Y, Shitara Y, Komiya T, Maeda S, Ito A, Yoshida M.

FEBS Lett. 2012 May 7;586(9):1379-83. doi: 10.1016/j.febslet.2012.03.060. Epub 2012 Apr 12.

31.

Mitochondrial P5, a member of protein disulphide isomerase family, suppresses oxidative stress-induced cell death.

Shitara Y, Tonohora Y, Goto T, Yamada Y, Miki T, Makino H, Miwa M, Komiya T.

J Biochem. 2012 Jul;152(1):73-85. doi: 10.1093/jb/mvs034. Epub 2012 Apr 4.

PMID:
22492663
32.

Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

Shitara Y, Takeuchi K, Nagamatsu Y, Wada S, Sugiyama Y, Horie T.

Drug Metab Pharmacokinet. 2012;27(4):368-78. Epub 2012 Jan 13.

33.

Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.

Tanii H, Shitara Y, Horie T.

Eur J Clin Pharmacol. 2011 Oct;67(10):1017-25. doi: 10.1007/s00228-011-1042-3. Epub 2011 Apr 15.

PMID:
21494765
34.

Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions.

Shitara Y.

Drug Metab Pharmacokinet. 2011 Jun;26(3):220-7. doi: 10.2133/dmpk.DMPK-10-RV-094. Epub 2011 Feb 1. Review.

35.

Rosai-Dorfman disease of the colon presented as small solitary polypoid lesion.

Ide M, Asao T, Yoshida T, Hirato J, Shimura T, Morinaga N, Shitara Y, Ishizaki M, Kuwano H.

Rare Tumors. 2010 Mar 31;2(1):e2. doi: 10.4081/rt.2010.e2.

36.

Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition.

Okuda T, Norioka M, Shitara Y, Horie T.

Toxicol Appl Pharmacol. 2010 Nov 1;248(3):242-8. doi: 10.1016/j.taap.2010.08.007. Epub 2010 Aug 12.

PMID:
20709092
37.

Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats.

Hamada K, Shitara Y, Sekine S, Horie T.

Cancer Chemother Pharmacol. 2010 Nov;66(6):1031-8. doi: 10.1007/s00280-010-1253-9. Epub 2010 Jan 30.

PMID:
20119715
38.

Pulmonary function after pulmonary resection by posterior thoracotomy, anterior thoracotomy or video-assisted surgery.

Endoh H, Tanaka S, Yajima T, Ito T, Tajima K, Mogi A, Shitara Y, Kuwano H.

Eur J Cardiothorac Surg. 2010 May;37(5):1209-14. doi: 10.1016/j.ejcts.2009.11.016. Epub 2009 Dec 21.

PMID:
20022519
39.

Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats.

Shitara Y, Nagamatsu Y, Wada S, Sugiyama Y, Horie T.

Drug Metab Dispos. 2009 Jun;37(6):1172-8. doi: 10.1124/dmd.108.025544. Epub 2009 Mar 12.

PMID:
19282398
40.

Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.

Watanabe T, Kusuhara H, Maeda K, Shitara Y, Sugiyama Y.

J Pharmacol Exp Ther. 2009 Feb;328(2):652-62. doi: 10.1124/jpet.108.146647. Epub 2008 Nov 10. Erratum in: J Pharmacol Exp Ther. 2011 May;337(2):568-9.

PMID:
19001154
41.

Impact of preexisting pulmonary fibrosis detected on chest radiograph and CT on the development of gefitinib-related interstitial lung disease.

Naito Y, Tsuchiya S, Ishihara S, Minato K, Shitara Y, Takise A, Suga T, Mogi A, Yamabe K, Saito R.

Am J Clin Oncol. 2008 Aug;31(4):340-4. doi: 10.1097/COC.0b013e318162f13b.

PMID:
18845992
42.

Gastric cancer with features of submucosal tumor: a case report.

Ando H, Morinaga N, Shitara Y, Suzuki K, Toyoda M, Kano H, Suzuki Y, Mochiki E, Kuwano H.

Hepatogastroenterology. 2008 May-Jun;55(84):1146-9.

PMID:
18705348
43.

The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.

Kato M, Shitara Y, Sato H, Yoshisue K, Hirano M, Ikeda T, Sugiyama Y.

Pharm Res. 2008 Aug;25(8):1891-901. doi: 10.1007/s11095-008-9607-2. Epub 2008 May 16.

PMID:
18483837
44.

Evidence for mitochondrial localization of P5, a member of the protein disulphide isomerase family.

Kimura T, Horibe T, Sakamoto C, Shitara Y, Fujiwara F, Komiya T, Yamamoto A, Hayano T, Takahashi N, Kikuchi M.

J Biochem. 2008 Aug;144(2):187-96. doi: 10.1093/jb/mvn057. Epub 2008 Apr 19.

PMID:
18424807
45.

CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.

Tanaka S, Saito K, Ito T, Tajima K, Mogi A, Shitara Y, Sano T, Kuwano H.

Oncol Rep. 2007 Jul;18(1):87-92.

PMID:
17549351
46.

Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.

Fujiyama N, Shitara Y, Ito K, Masubuchi Y, Horie T.

Biol Pharm Bull. 2007 Mar;30(3):556-61.

48.

Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.

Liu L, Cui Y, Chung AY, Shitara Y, Sugiyama Y, Keppler D, Pang KS.

J Pharmacol Exp Ther. 2006 Jul;318(1):395-402. Epub 2006 Apr 20.

PMID:
16627748
49.

Drug-drug interaction between pitavastatin and various drugs via OATP1B1.

Hirano M, Maeda K, Shitara Y, Sugiyama Y.

Drug Metab Dispos. 2006 Jul;34(7):1229-36. Epub 2006 Apr 4.

PMID:
16595711
50.

Transporters as a determinant of drug clearance and tissue distribution.

Shitara Y, Horie T, Sugiyama Y.

Eur J Pharm Sci. 2006 Apr;27(5):425-46. Epub 2006 Feb 20. Review.

PMID:
16488580

Supplemental Content

Loading ...
Support Center